Regulation of leptin, adiponectin and acylation-stimulating protein by hyperinsulinaemia and hyperglycaemia in vivo in healthy lean young men

Diabetes and Metabolism

Volumn 34, Issue 4, 2008, Pages 334-342

  Faraj, M ^a,b   Beauregard, G ^a   Tardif, A ^a,b   Loizon, E ^c   Godbout, A ^b   Cianflone, K ^d   Vidal, H ^c   Rabasa Lhoret, R ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSERM   (France)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

Acylation stimulating protein; Adiponectin; Adipose tissue hormones; C3adesArg; Healthy subjects; Hyperglycaemic clamp; Hyperinsulinaemic clamp; Insulin; Leptin; Ob gene; Somatostatin

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPONECTIN; INSULIN; LEPTIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; SOMATOSTATIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; GENE EXPRESSION; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERINSULINEMIA; IN VIVO STUDY; LEAN BODY WEIGHT; MALE; METABOLIC REGULATION; SUBCUTANEOUS FAT;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ADULT; BLOOD GLUCOSE; COMPLEMENT C3; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN; LEPTIN; MALE; SOMATOSTATIN;

EID: 51849128291     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.01.014     Document Type: Article

References (39)

1. Faraj M., Lu H.L., and Cianflone K. Diabetes, lipids, and adipocyte secretagogues. Biochem Cell Biol 82 (2004) 170-190
2. Perseghin G., Lattuada G., Danna M., Sereni L.P., Maffi P., De Cobelli F., et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 285 (2003) E1174-E1181
3. Fischer S., Hanefeld M., Haffner S.M., Fusch C., Schwanebeck U., Kohler C., et al. Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetol 39 (2002) 105-110
4. Koistinen H.A., Vidal H., Karonen S.L., Dusserre E., Vallier P., and Koivisto V.A. Plasma acylation-stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Throm Vasc Biol 21 (2001) 1034-1039
5. Ozata M., Gungor D., Turan M., Ozisik G., Bingol N., Ozgurtas T., et al. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects. J Clin Endocrinol Metab 86 (2001) 3659-3664
6. Cianflone K., Xia Z., and Chen L.Y. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 1609 (2003) 127-143
7. Yang Y., Lu H.L., Zhang J., Yu H.Y., Wang H.W., Zhang M.X., et al. Relationships among acylation-stimulating protein, adiponectin and complement C3 in lean versus obese type 2 diabetes. Int J Obesity 30 (2005) 439-446
8. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
9. Statnick M.A., Beavers L.S., Conner L.J., Corominola H., Johnson D., Hammond C.D., et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diab Res 1 (2000) 81-88
10. Imagawa A., Funahashi T., Nakamura T., Moriwaki M., Tanaka S., Nishizawa H., et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 25 (2002) 1665-1666
11. Sandoval D.A., Galassetti P., Tate D., Neill A., and Davis S.N. Leptin responses to antecedent exercise and hypoglycemia in healthy and type 1 diabetes mellitus men and women. J Diabetes Complications 17 (2003) 301-306
12. Faraj M., Beauregard G., Loizon E., Moldes M., Clément K., Tahiri Y., et al. Insulin regulation of gene expression and concentrations of white adipose tissue-derived proteins in vivo in healthy men: relation to adiponutrin. J Endocrinol 191 (2006) 427-435
13. Ducluzeau P.H., Perretti N., Laville M., Andreelli F., Vega N., Riou J.P., et al. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue: evidence for specific defects in type 2 diabetes. Diabetes 50 (2001) 1134-1142
14. Lefai E., Roques M., Vega N., Laville M., and Vidal H. Expression of the splice variants of the p85alpha regulatory subunit of phosphoinositide 3-kinase in muscle and adipose tissue of healthy subjects and type 2 diabetic patients. Biochem J 360 (2001) 117-126
15. Saltiel A.R., and Kahn R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
16. Vidal H., Auboeuf D., De Vos P., Staels B., Riou J.P., Auwerx J., et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 98 (1996) 251-255
17. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metabol 237 (1979) E214-E223
18. Meneilly G.S., Ryan E.A., Radziuk J., Lau D.C., Yale J.F., Morais J., et al. Effect of acarbose on insulin sensitivity in elderly patients with diabetes. Diabetes Care 23 (2000) 1162-1167
19. Prato S.D., Matsuda M., Simonson D.C., Groop L.C., Sheehan P., Leonetti F., et al. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia 40 (1997) 687-697
20. Maslowska M., Vu H., Phelis S., Sniderman A.D., Rhode B.M., Blank D., et al. Plasma acylation-stimulating protein, adipsin and lipids in non-obese and obese populations. Euro J Clin Inv 29 (1999) 679-686
21. Baba A., Harper J., and Buttery P. Effects of gastric inhibitory polypeptide, somatostatin and epidermal growth factor on lipogenesis in ovine adipose explants. Comp Biochem Physiol B Biochem Mol Biol 127 (2000) 173-182
22. Liu J., Askari H., and Dagogo-Jack S. Reproducibility of fasting plasma leptin concentration in lean and obese humans. Endocr Res 25 (1999) 1-10
23. Shand B., Elder P., Scott R., Frampton C., and Willis J. Biovariability of plasma adiponectin. Clin Chem Lab Med 44 (2006) 1264-1268
24. Casabiell X., Pineiro V., De la Cruz L.F., Gualillo O., Folgar L., Dieguez C., et al. Dual effect of insulin on in vitro leptin secretion by adipose tissue. Biochem Biophys Res Commun 276 (2000) 477-482
25. Saad M.F., Khan A., Sharma A., Michael R., Riad-Gabriel M.G., Boyadjian R., et al. Physiological insulinemia acutely modulates plasma leptin. Diabetes 47 (1998) 544-549
26. Malmstrom R., Taskinen M.R., Karonen S.L., and Yki-Jarvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 39 (1996) 993-996
27. Garcia-Lorda P., Nash W., Roche A., Pi-Sunyer F.X., and Laferrere B. Intralipid/heparin infusion suppresses serum leptin in humans. Eur J Endocrinol 148 (2003) 669-676
28. Donahoo W.T., Jensen D.R., Yost T.J., and Eckel R.H. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab 82 (1997) 4139-4143
29. Ahima R.S., and Flier J.S. Leptin. Annu Rev Physiol 62 (2000) 413-437
30. Yu J.G., Javorschi S., Hevener A.L., Kruszynska Y.T., Norman R.A., Sinha M., et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51 (2002) 2968-2974
31. Westerbacka J., Cornér A., Kannisto K., Kolak M., Makkonen J., Korsheninnikova E., et al. Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects. Diabetologia 49 (2006) 132-140
32. Bueno A., Oyama L., de Oliveira C., Pisani L., Ribeiro E., Silveira V., et al. Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue. Pflugers Arch 455 (2008) 701-709
33. Pérez-Matute P., Martinez J., Marti A., and Moreno-Aliage M. Linoleic acid decreases leptin and adiponectin secretion from primary rat adipocytes in the presence of insulin. Lipids 42 (2007) 913-920
34. Perez-Matute P., Marti A., Martinez J.A., Fernandez-Otero M.P., and Stanhope K.L. Havel PJ et al. Conjugated linoleic acid inhibits glucose metabolism, leptin and adiponectin secretion in primary cultured rat adipocytes. Mol Cell Endocrinol 268 (2007) 50-58
35. Goodman R., Rehfuss R., Verhave M., Ventimiglia R., and Lowe M.J. Somatostatin gene regulation: an overview. Metabolism 39 (1990) 2-5
36. Simon M.A., Romero B., and Calle C. Characterization of somatostatin binding sites in isolated rat adipocytes. Regul Pept 23 (1988) 261-270
37. Maslowska M., Scantlebury T., Germinario R., and Cianflone K. Acute in vitro production of ASP in differentiated adipocytes. J Lipid Res 38 (1997) 21-31
38. Cianflone K., Sniderman A.D., Kalant D., Marliss E.B., and Gougeon R. Response of plasma ASP to a prolonged fast. Int J Obesity 19 (1995) 604-609
39. Baldo A., Sniderman A.D., St-Luce S., Avramoglu R.K., Maslowska M., Hoang B., et al. The adipsin-acylation-stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 92 (1993) 1543-1547